July 11, 2013
Major pharmaceutical companies are likely to disclose information this summer on their R&D expenses and research grants provided to medical and research institutes in FY2012, based on the transparency guidelines of the Japan Pharmaceutical Manufacturers Association (JPMA). It will be...read more